Literature DB >> 14715470

The possible role of one-electron reduction of aminochrome in the neurodegenerative process of the dopaminergic system.

J Segura-Aguilar1, D Metodiewa, S Baez.   

Abstract

We present for discussion a possible molecular mechanism explaining the formation of reactive oxygen species involved in the neurodegenerative process of dopaminergic system in Parkinson's disease. This new hypothesis involves one-electron reduction of aminochrome to o-semiquinone radical, which seems to be the reaction responsible for neurodegenerative process of dopaminergic system. Leukoaminochrome o-semiquinone is extremely reactive with oxygen, which reoxidizes by reducing oxygen to superoxide radicals. Superoxide radicals enzymatically or spontaneously dismutate to dioxygen and hydrogen peroxide which is a precursor of hydroxyl radicals. ESR-experiments have showed that aminochrome o-semiquinone is extremely reactive in the presence of oxygen compared to dopamine o-semiquinone. In addition, the antioxidant enzymes superoxide dismutase and catalase play a prooxidant role by increasing the autoxidation rate and formation of superoxide radicals. One electron reduction of aminochrome to o-semiquinone can be performed by flavoenzymes which use NADPH and NADH as electron donator. The ability of aminochrome o-semiquinone to autoxidize in the presence of oxygen gives rise to a redox cycling process which will continue until oxygen, NADH and/or NADPH are depleted. Depletion of NADPH will prevent glutathione reductase from reducing glutathione, which is one of the main antioxidants in the cell. In addition depletion of NADH will prevent the formation of ATP in the electron transport chain in the mitochondria. Two antioxidants, probably, neuroprotective reactions are also discussed.

Entities:  

Year:  2001        PMID: 14715470     DOI: 10.1007/bf03033188

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  29 in total

1.  The chemistry of melanin; mechanism of the oxidation of dihydroxyphenylalanine by tyrosinase.

Authors:  H S MASON
Journal:  J Biol Chem       Date:  1948-01       Impact factor: 5.157

2.  Catecholamines oxidation by xanthine oxidase.

Authors:  C Foppoli; R Coccia; C Cini; M A Rosei
Journal:  Biochim Biophys Acta       Date:  1997-03-15

3.  Superoxide dismutase and catalase enhance autoxidation during one-electron reduction of aminochrome by NADPH-cytochrome P-450 reductase.

Authors:  S Baez; Y Linderson; J Segura-Aguilar
Journal:  Biochem Mol Med       Date:  1995-02

4.  Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA. Implications for the treatment of Parkinson's disease.

Authors:  G Walkinshaw; C M Waters
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

5.  Dopamine, 6-hydroxydopamine, iron, and dioxygen--their mutual interactions and possible implication in the development of Parkinson's disease.

Authors:  W Linert; E Herlinger; R F Jameson; E Kienzl; K Jellinger; M B Youdim
Journal:  Biochim Biophys Acta       Date:  1996-08-23

6.  Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes.

Authors:  S Baez; J Segura-Aguilar; M Widersten; A S Johansson; B Mannervik
Journal:  Biochem J       Date:  1997-05-15       Impact factor: 3.857

7.  Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

Authors:  T G Hastings; D A Lewis; M J Zigmond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

8.  On the mechanism of the Mn3(+)-induced neurotoxicity of dopamine:prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase.

Authors:  J Segura-Aguilar; C Lind
Journal:  Chem Biol Interact       Date:  1989       Impact factor: 5.192

9.  Generation of the neurotoxin 6-hydroxydopamine by peroxidase/H2O2 oxidation of dopamine.

Authors:  A Napolitano; O Crescenzi; A Pezzella; G Prota
Journal:  J Med Chem       Date:  1995-03-17       Impact factor: 7.446

10.  Dopamine-induced programmed cell death in mouse thymocytes.

Authors:  D Offen; I Ziv; S Gorodin; A Barzilai; Z Malik; E Melamed
Journal:  Biochim Biophys Acta       Date:  1995-08-31
View more
  6 in total

Review 1.  Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease.

Authors:  Irmgard Paris; Sergio Cardenas; Jorge Lozano; Carolina Perez-Pastene; Rebecca Graumann; Alejandra Riveros; Pablo Caviedes; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2007-09       Impact factor: 3.911

2.  Cytotoxicity of dopaminochrome in the mesencephalic cell line, MN9D, is dependent upon oxidative stress.

Authors:  Andrew J Linsenbardt; Gerald H Wilken; Thomas C Westfall; Heather Macarthur
Journal:  Neurotoxicology       Date:  2009-07-18       Impact factor: 4.294

3.  MPP(+)-induced degeneration is potentiated by dicoumarol in cultures of the RCSN-3 dopaminergic cell line. Implications of neuromelanin in oxidative metabolism of dopamine neurotoxicity.

Authors:  R Aguilar Hernández; M J Sánchez De Las Matas; C Arriagada; C Barcia; P Caviedes; M T Herrero; J Segura-Aguilar
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

4.  Molecular and neurochemical mechanisms in PD pathogenesis.

Authors:  Irmgard Paris; Jorge Lozano; Carolina Perez-Pastene; Patricia Muñoz; Juan Segura-Aguilar
Journal:  Neurotox Res       Date:  2009-05-20       Impact factor: 3.911

5.  Effects of the DT-diaphorase inhibitor dicumarol on striatal monoamine levels in L-DOPA and L-deprenyl pre-treated rats.

Authors:  Diego Bustamante; L Bustamante; Juan Segura-Aguilar; Michel Goiny; Mario Herrera-Marschitz
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.978

6.  Norepinephrine and its metabolites are involved in the synthesis of neuromelanin derived from the locus coeruleus.

Authors:  Kazumasa Wakamatsu; Keisuke Tabuchi; Makoto Ojika; Fabio A Zucca; Luigi Zecca; Shosuke Ito
Journal:  J Neurochem       Date:  2015-09-04       Impact factor: 5.372

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.